| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CHIR-99021 | GDSC1000 | pan-cancer | AAC | -0.036 | 0.3 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.054 | 0.3 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.3 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.035 | 0.3 |
| mRNA | PHA-793887 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.3 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.036 | 0.3 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | -0.037 | 0.3 |